Skip to main content
PolicySpeak
← The ranking

Side by side

Compare organizations

Consultation participation and their own register declarations, side by side. Counts, not judgments — participation is not influence.

Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

PRM
Pharmaceutical Research and Manufacturers of America

Industry association · United States

2
files engaged
of 583 tracked
2
positions filed
in those 583 files
declared FTE
self-declared
EP accreditations
as declared to the register
BUS
BusinessEurope

Industry association · Belgium

21
files engaged
of 583 tracked
22
positions filed
in those 583 files
31
declared FTE
self-declared
22
EP accreditations
as declared to the register

Declared costs: €6M+ a year · in the register since 2009

Files both filed on (2)

Compulsory licensing of patents in crisis situations · Supplementary protection certificate for plant protection products. Recast

Register facts self-declared (snapshot 2 Sept 2026); cost bands are floors. Shared files are shared attention, not evidence of coordination.

What each said, in their own words

Their opening passages on the files they share, verbatim and in filing order. We do not summarize, compare, or characterize positions — read them at source.

Compulsory licensing of patents in crisis situations

Pharmaceutical Research and Manufacturers of America · filed 29 Apr 2022 · source

PhRMA, and the innovative biopharmaceutical companies that it represents, has serious concerns with the call for legislative action regarding compulsory licensing in the EU and its Member States. While the call for evidence recognizes that compulsory licensing should be a tool of last resort, it suggests that there is a need for a central compulsory licensing mechanism in Europe for use in a potential crisis.

BusinessEurope · filed 19 Jul 2023 · source

BUSINESSEUROPE is the leading advocate for growth and competitiveness at the European level, standing up for companies across the continent and actively campaigning on the issues that most influence their performance. We speak for enterprises of all sizes in 35 European countries whose national business federations are our direct members. Patents are meant to stimulate innovation.

Supplementary protection certificate for plant protection products. Recast

Pharmaceutical Research and Manufacturers of America · filed 5 Apr 2022 · source

The Pharmaceutical Research and Manufacturers of America, and the innovative biopharmaceuticals companies that they represent, commend the European Commission’s call for the development of a single procedure for the granting of supplementary protection certificates (SPCs) in Europe.

BusinessEurope · filed 19 Jul 2023 · source

BUSINESSEUROPE is the leading advocate for growth and competitiveness at the European level, standing up for companies across the continent and actively campaigning on the issues that most influence their performance. We speak for enterprises of all sizes in 35 European countries whose national business federations are our direct members.

Take this comparison with you

2 organizations on one sheet: every file each filed on, their register declarations, and a working link to each submission. Free: we ask for your name and email, and PolicySpeak may contact you about the product (privacy policy). The per-file record stays downloadable without signing up on each file’s page.